當前位置: 華文世界 > 科學

數量位居世界第二!2023年中國皮膚科基礎研究重要進展,8表總結

2024-07-05科學

* 僅供醫學專業人士閱讀參考

8張表格,快速理清!


撰文丨 楊鳳娟


近日,在山東省青島世界博覽城盛大召開的 第二十九次皮膚性病學術年會(CSD 2024)上,中國醫學科學院皮膚病醫院陸前進教授 詳細介紹了2023年中國皮膚科基礎研究的科研成果。


圖1:陸前進教授作精彩報告


陸前進教授首先分享到,全球皮膚科發表了19,210篇Medline收錄的文獻,其中中國發表了3,370篇,數量位居世界第二。中國的基礎研究主要集中在 銀屑病、特應性皮炎和黑色素瘤 三大疾病上,熱點方向包括微生物組學、細胞多組學、代謝重編程和神經免疫。


表1:2023年中國皮膚科主要科研進展總覽


1、皮膚生物學——傷口愈合與毛囊再生

表2:2023年皮膚生物學主要科研進展


2、玫瑰痤瘡

表3:2023年玫瑰痤瘡主要科研進展


3、銀屑病


表4:2023年銀屑病主要科研進展


4、紅斑狼瘡

表5:2023年紅斑狼瘡主要科研進展


5、天皰瘡、類天皰瘡

表6:2023年天皰瘡、類天皰瘡主要科研進展


6、特應性皮炎


表7:2023年特應性皮炎主要科研進展


7、黑色素瘤

表8:2023年黑色素瘤主要科研進展


陸前進教授展望了中國皮膚科科研的發展,指出隨著基礎研究的深入,越來越多的新細胞亞群、新發病機制和新藥物靶點被發現,為全面解析皮膚病的發病機制提供理論基礎,並為未來的診療策略提供新方向。


專家簡介

陸前進 教授

  • 中國醫學科學院皮膚病醫院教授、博士生導師、主任醫師

  • 北京協和醫學院長聘教授

  • 中國醫學科學院學部委員

  • 中華醫學會皮膚性病學分會第十五屆主任委員

  • 中國免疫學會皮膚免疫分會主任委員

  • 中國醫師協會皮膚科分會副會長

  • 國際皮膚科學會聯盟常務理事

  • 中華皮膚科雜誌總編輯

  • Clinical Immunology 雜誌副主編

  • Exp Dermatol 雜誌副主編

  • 更多皮膚前沿內容


    快來「 醫生站網 頁版 」瞧一瞧 👇

    或點選閱讀原文

    精彩資訊等你來

    參考文獻:

    [1] Yin J, Shi D, Sun Y.et al. IRF7 and CTSS are pivotal for cutaneous wound healing and may serve as therapeutic targets[J]. Signal Transduction and Targeted Therapy, Nature Publishing Group, 2023, 8(1): 1–4.

    [ 2] Wang G, Sweren E, Andrews W.et al. Commensal microbiome promotes hair follicle regeneration by inducing keratinocyte HIF-1α signaling and glutamine metabolism[J]. Science Advances, American Association for the Advancement of Science, 2023, 9(1): eabo7555.

    [3 ] Deng Z, Chen M, Zhao Z.et al. Whole genome sequencing identifies genetic variants associated with neurogenic inflammation in rosacea[J]. Nature Communications, 2023, 14(1): 3958.

    [4 ] Zhao Q, Yu J, Zhou H.et al. Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism[J]. Signal Transduction and Targeted Therapy, Nature Publishing Group, 2023, 8(1): 1–18.

    [5 ] Cai X, Han M, Lou F.et al. Tenascin C+ papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis[J]. Nature Communications, Nature Publishing Group, 2023, 14(1): 2004.

    [6 ] Chen J, Bai Y, Xue K.et al. CREB1-driven CXCR4hi neutrophils promote skin inflammation in mouse models and human patients[J]. Nature Communications, Nature Publishing Group, 2023, 14(1): 5894.

    [7 ] Lu J, Zhong X, Guo C.et al. TLR7-MyD88-DC-CXCL16 axis results neutrophil activation to elicit inflammatory response in pustular psoriasis[J]. Cell Death & Disease, Nature Publishing Group, 2023, 14(5): 1–13.

    [8 ] Li Q, Shao S, Zhu Z.et al. An IGFBP7hi endothelial cell subset drives T cell extravasation in psoriasis via endothelial glycocalyx degradation[J]. The Journal of Clinical Investigation, American Society for Clinical Investigation, 2023, 133(9).

    [9 ] Chen C, Yi X, Liu P.et al. CD147 Facilitates the Pathogenesis of Psoriasis through Glycolysis and pK9me3 Modification in Keratinocytes[J]. Research, American Association for the Advancement of Science, 2023, 6: 0167.

    [10 ] Tian J, Zhang D, Yao X.et al. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study[J]. Annals of the Rheumatic Diseases, BMJ Publishing Group Ltd, 2023, 82(3): 351–356.

    [11 ] Zhao M, Feng D, Hu L.et al. 3D genome alterations in T cells associated with disease activity of systemic lupus erythematosus[J]. Annals of the Rheumatic Diseases, BMJ Publishing Group Ltd, 2023, 82(2): 226–234.

    [12 ] Guo Z, Yiu N, Hu Z.et al. Alterations of fecal microbiome and metabolome in pemphigus patients[J]. Journal of Autoimmunity, 2023, 141: 103108.

    [13 ] Xu C, Zhang T, Wang H.et al. Integrative single-cell analysis reveals distinct adaptive immune signatures in the cutaneous lesions of pemphigus[J]. Journal of Autoimmunity, 2024, 142: 103128.

    [14 ] Liu X, Xu B, Xu X.et al. Attenuation of allergen-specific immunotherapy for atopic dermatitis by ectopic colonization of Brevundimonas vesicularis in the intestine[J]. Cell Reports Medicine, Elsevier, 2023, 4(12).

    [15 ] Qiu Z, Zhu Z, Liu X.et al. A dysregulated sebum–microbial metabolite–IL-33 axis initiates skin inflammation in atopic dermatitis[J]. Journal of Experimental Medicine, 2022, 219(10): e20212397.

    [16 ] Tian J, Zhang D, Yang Y.et al. Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study[J]. British Journal of Dermatology, 2024, 190(1): 55–61.

    [17 ] Yi X, Wang H, Yang Y.et al. SIRT7 orchestrates melanoma progression by simultaneously promoting cell survival and immune evasion via UPR activation[J]. Signal Transduction and Targeted Therapy, Nature Publishing Group, 2023, 8(1): 1–17.

    [18 ] Meng Y, Sun H-Y, He Y.et al. BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition[J]. Military Medical Research, 2023, 10(1): 61.

    [19 ] Zeng F, Li Y, Meng Y.et al. BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression[J]. Experimental & Molecular Medicine, Nature Publishing Group, 2023, 55(2): 364–376.

    [20 ] Liu N, Chen L, Yan M.et al. Eubacterium rectale Improves the Efficacy of Anti-PD1 Immunotherapy in Melanoma via l-Serine-Mediated NK Cell Activation[J]. Research, American Association for the Advancement of Science, 2023, 6: 0127.

    本文稽核:陸前進教授

    責任編輯: 劉思思


    *"醫學界"力求所發表內容專業、可靠,但不對內容的準確性做出承諾;請相關各方在采用或以此作為決策依據時另行核查。